Nautilus Biotechnology (NAUT) Shares Outstanding (Diluted) (2020 - 2026)
Nautilus Biotechnology (NAUT) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 64.41 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 115.80 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 138.28 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 556.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Nautilus Biotechnology | 114.43 Mn | 114.43 Mn | 175,000.00 | 127.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 127.14 Mn |
| Mar 31, 2026 | 126.63 Mn |
| Dec 31, 2025 | 126.26 Mn |
| Sep 30, 2025 | 126.31 Mn |
| Jun 30, 2025 | 126.20 Mn |
| Mar 31, 2025 | 126.14 Mn |
| Dec 31, 2024 | 125.43 Mn |
| Sep 30, 2024 | 125.45 Mn |
| Jun 30, 2024 | 125.32 Mn |
| Mar 31, 2024 | 125.14 Mn |
| Dec 31, 2023 | 124.92 Mn |
| Sep 30, 2023 | 124.93 Mn |
| Jun 30, 2023 | 124.60 Mn |
| Mar 31, 2023 | 124.59 Mn |
| Dec 31, 2022 | 124.59 Mn |
| Sep 30, 2022 | 124.65 Mn |
| Jun 30, 2022 | 124.49 Mn |
| Mar 31, 2022 | 124.42 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 124.11 Mn |